Evidence map›Paper›PMID 33651706›Full record

ArticleJMIR mental health2021

Feasibility and Initial Outcomes of a Group-Based Teletherapy Psychiatric Day Program for Adults With Serious Mental Illness: Open, Nonrandomized Trial in the Context of COVID-19.

Ajeng J Puspitasari, Dagoberto Heredia, Brandon J Coombes, Jennifer R Geske, Melanie T Gentry, Wendy R Moore, Craig N Sawchuk, Kathryn M Schak

Open access · goldAbstract read
In one paragraph

Article in JMIR mental health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ajeng J PuspitasariDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0002-8552-7498
Dagoberto HerediaDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0002-6725-836X
Brandon J CoombesDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0003-4322-5923
Jennifer R GeskeDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0002-7341-1535
Melanie T GentryDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0002-9484-3206
Wendy R MooreDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0002-9857-797X
Craig N SawchukDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0001-6293-953X
Kathryn M SchakDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.ORCID https://orcid.org/0000-0002-4726-3380
Mayo Clinic in Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the context of the COVID-19 pandemic, many behavioral health services have transitioned to teletherapy to continue delivering care for patients with mental illness. Studies that evaluate the outcome of this rapid teletherapy adoption and implementation are pertinent.

objectiveThis single-arm, nonrandomized pilot study aimed to assess the feasibility and initial patient-level outcomes of a psychiatric transitional day program that switched from an in-person group to a video teletherapy group during the COVID-19 pandemic.

methodsPatients with transdiagnostic conditions who were at risk of psychiatric hospitalization were referred to the Adult Transitions Program (ATP) at a large academic medical center in the United States. ATP was a 3-week intensive outpatient program that implemented group teletherapy guided by cognitive and behavioral principles delivered daily for 3 hours per day. Feasibility was assessed via retention, attendance rate, and rate of securing aftercare appointments prior to ATP discharge. Patients completed standardized patient-reported outcome measures at admission and discharge to assess the effectiveness of the program for improving quality of mental health, depression, anxiety, and suicide risk.

resultsPatients (N=76) started the program between March and August of 2020. Feasibility was established, with 70 of the 76 patients (92%) completing the program and a mean attendance of 14.43 days (SD 1.22); also, 71 patients (95%) scheduled at least one behavioral health aftercare service prior to ATP discharge. All patient-level reported outcomes demonstrated significant improvements in depression (95% CI -3.6 to -6.2; Cohen d=0.77; P<.001), anxiety (95% CI -3.0 to -4.9; Cohen d=0.74; P<.001), overall suicide risk (95% CI -0.5 to -0.1; Cohen d=0.41; P=.02), wish to live (95% CI 0.3 to 1.0; Cohen d=0.39; P<.001), wish to die (95% CI -0.2 to -1.4; Cohen d=0.52; P=.01), and overall mental health (95% CI 1.5 to 4.5; Cohen d=0.39; P<.001) from admission to discharge.

conclusionsRapid adoption and implementation of a group-based teletherapy day program for adults at risk of psychiatric hospitalization appeared to be feasible and effective. Patients demonstrated high completion and attendance rates and reported significant improvements in psychosocial outcomes. Larger trials should be conducted to further evaluate the efficacy and effectiveness of the program through randomized controlled trials.

Indexed as

behavioral scienceCOVID-19effectivefeasibilityimplementationintensive outpatientmental healthoutcomepilotserious mental illnesstelehealthtelemedicineteletherapytherapy

Identifiers

PMID33651706
PMCPMC7954114
OpenAlexW3134196732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.